Organon & Company (OGN)

Health Care · Pharmaceutical Preparations

Turbulence: High Sector-strength: 64th pctile elevated vs peers

Organon & Company sits in the High turbulence band, around the 64th percentile of Health Care on balance-sheet strength. The lens reads it as elevated vs peers. The underlying figures, all from public filings:

Revenue (TTM) $6.2B
Net income (TTM) $187M
Operating margin 14.9%
FCF margin 8.7%
Altman Z n/a
Piotroski F 5
Beneish M n/a
Interest coverage 1.843

See the full deep-dive in the app →

Figures from public filings (EDGAR). Descriptive, not advice. No targets, no buy or sell. Price and valuation live in the app.

Get the weekly read by email

The Filter covers the macro backdrop and where balance-sheet strength matters, in the same language as the page above. Descriptive only.

No spam, and the list is never sold or shared. Unsubscribe from any issue.